NeoMero-1, Efficacy, pharmacokinetics and safety of Meropenem in infants below 90 days of age (inclusive) with clinical or confirmed late-onset sepsis: a European multicentre randomised phase III trial
KADIOĞLU ŞİMŞEK G., Kanmaz Kutman H. G., Canpolat F. E.
2010 - 2015
- Başlama Tarihi: Ocak 2010
- Bitiş Tarihi: Haziran 2015